Trump announces Medicaid drug price deals with nine pharma firms
–
Neutral summary
The Trump administration has struck drug pricing agreements with nine biotech and pharmaceutical companies, including UCB SA, Bridgebio Pharma and Sun Pharmaceutical Industries, to lower costs for Medicaid. President Trump said every drug “will be at the lowest prices available anywhere in the world.” The White House said the deals are projected to save Americans $600 billion and will reduce costs for treating Parkinson's disease, macular degeneration, glaucoma and liver disease. Experts, however, are skeptical about the impact on overall prices, saying other factors likely explain most of the recent decline in prescription drug costs.
How it was framed
Outlets: 12. Countries: 4. Facts in the shared core: 11.
Publication timeline
-
·
NBC News (outlet profile)
Trump makes announcement on healthcare affordability. Watch live coverage as President Trump makes an announcement on healthcare affordability during a White House event.
-
·
CNBC (outlet profile)
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers. The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
-
·
The Hill (outlet profile)
Watch live: Trump makes announcement on drug pricing. President Trump will make an announcement Monday afternoon tied to his efforts to make healthcare more affordable — after insurance prices skyrocketed when expanded…
-
·
Bloomberg (outlet profile)
Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms. The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and…
-
·
New York Post (outlet profile)
Trump unveils more prescription drug pricing discounts projected to save Americans $600B: ‘Major step forward’. Under the most-favored nation agreement the president announced Monday, drug prices in the United States wi…
-
·
Newsweek (outlet profile)
Donald Trump Announces Pharma Deal: List of Drugs Getting Prices Reduced. Trump expanded his drug pricing initiative with 9 pharma firms, targeting costs for seizure, transplant and other medications.
-
·
The Hill (outlet profile)
Trump announces Medicaid drug pricing deals with 9 firms. The Trump administration on Monday announced new Medicaid drug pricing agreements with nine midsize biotechnology and pharmaceutical companies. Every drug “will…
-
·
CBS News (outlet profile)
Trump inks deal with 9 pharmaceutical companies to lower drug costs. The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver disease and other illnesses.
-
·
Ведомости (outlet profile)
Администрация Трампа заключила соглашения о снижении цен на лекарства
-
·
FactCheck.org (outlet profile)
Trump Claims Credit for Drug Price Decline. Experts Say It’s More Complicated.. President Donald Trump and other administration officials are claiming credit for a recent drop in prescription drug prices, citing deals t…
-
·
BFMTV (outlet profile)
Donald Trump annonce de nouveaux accords avec les entreprises pharmaceutiques. Le président Donald Trump fait des annonces depuis la Maison blanche à Washington, ce lundi 31 août.
-
·
Newsweek (outlet profile)
Medicare Update: Hundreds of Thousands Get GLP-1 Drugs for Just $50. Before the new program, patients often faced out-of-pocket expenses that could exceed $1,000 per month.
-
·
Sydney Morning Herald (outlet profile)
CSL signs deal with Trump administration to slash prices for its medicines. Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slappe…
-
·
Time (outlet profile)
What Trump's Most-Favored-Nation Deal Means for Drug Prices. A deal with pharmaceutical companies may not be as far-reaching as the administration says, according to experts.
Factual core
- The Trump administration announced a most-favored-nation deal with pharmaceutical companies to lower drug prices.
- The deal involves agreements with pharmaceutical companies.
- The announcement was made at a White House event.
- The impact of the deal on drug prices is uncertain.
- The Trump administration imposed 100 percent tariffs on Australian-made pharmaceuticals.
- The agreements are part of a broader effort to reduce healthcare costs.
- The agreements were finalized during the Trump administration's tenure.
- Experts are skeptical that the administration's measures have had much impact on overall drug prices.
- Experts say other factors likely explain most of the decline in prescription drug prices.
- The announcement took place on Monday, August 31.
- CSL agreed to lower the cost of its medicines in the US.